Cardiovascular Flashcards

(42 cards)

1
Q

Diuretics, ACE inhibitors (cause for COUGH), angiotensin II receptor blockers (ARBs), calcium channel blockers

A

Essential Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diuretics, ACE inhibitors, angiotensin II receptor blockers, beta-blockers, K+-sparring agents

A

CHF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACE inhibitors, angiotensin II receptor blockers, diuretics, calcium channel blockers, beta-blockers, alpha-blockers

A

Diabetes mellitus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Use them cautiously in decompensated CHF

Contraindicated in cardiogenic shock

A

Beta-blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

They are protective against diabetic neuropathy

A

ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Block voltage-dependent L-type calcium channels

cardiac and smooth muscle

HTN, angina, arrhythmias, Prinzmetal’s angina, Raynaud’s

Cardiac depression, AV block, peripheral edema, flushing, dizziness, constipation

A

Calcium channel blockers

Nifedipine, verapamil, diltiazem, amlodipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tissue where:

amlodipine = nifedipine > diltiazem > verapamil

A

Vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tissue where:

verapamil > diltiazem > amlodipine = nifedipine

A

Heart muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Causes smooth muscle relaxation due to increased cGMP

Arterioles > veins

(afterload reduction)

Severe HTN, CHF

1st line: HTN in pregnancy

Compensatory tachycardia, fluid retention, nausea, headache, angina, lupus-like syndrome

A

Hydralazine

Add methyldopa for HTN in pregnancy

Add beta-blocker to prevent reflex tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Direct release of NO increases cGMP

Malignant HTN

S.E. Cyanide toxicity at large doses

A

Nitroprusside

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

D1 receptor agonist

coronary, peripheral, renal, splanchnic vasodilation

Decreases BP (vasodilation) so used for Malignant HTN via

Increases Na+ loss

A

Fenoldopam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nitroprusside, nicardipine, clevidipine, labetalol, fenoldopam

A

Malignant HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Release NO in smooth muscle

Increases cGMP

Veins >> arteries

(decreased preload)

Angina, pulmonary edema

Reflex tachycardia, hypotension, flushing, headache, Monday disease

A

Nitroglycerin,

Isosorbide dinitrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dizziness, tachycardia (reflec to NO dilation effects), headache

Loss of tolerance over weekend

Develop tolerance during work week

A

Monday disease

Due to nitroglycerin reexposure at beginning of work week.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

These are determinants of what?

End-diastolic volume, blood pressure, heart rate, contractility, ejection time

A

Myocardial O2 consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Contraindicated in angina

(2)

A

Partial beta-agonists

Pindolol, acebutolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which Calcium Channel Blocker (CCB) is similar to:

Nitrates

and

beta-blockers

A

Nifedipine - nitrates

and

Verapamil - beta-blockers

18
Q

Effects of nitrates:

EDV

BP

Contractility

HR

Ejection time

MVO2

A

EDV - decrease

BP - decrease

Contractility - increase (reflex)

HR - increase (reflex)

Ejection time - decrease

MVO2 - decrease

19
Q

Effects of beta-blockers:

EDV

BP

Contractility

HR

Ejection time

MVO2

A

EDV - increase

BP - decrease

Contractility - decrease

HR - decrease

Ejection time - increase

MVO2 - decrease

20
Q

Combined nitrates and beta-blockers reduce what?

(3)

A

BP, HR, MVO2 (greatly)

21
Q

Inhibit conversion of HMG-CoA to mevalonate

Greatly reduces LDL

Slightly increases HDL

Hepatotoxicity, rhabdomyolysis (muscle breakdown)

A

HMG-CoA reductase inhibitors

Lovastatin, pravastatin, simvastatin, atorvastatin, rosuvastatin

22
Q

Reduces hepatic VLDL secretion

Inhibits lipolysis in adipose tissue

Greatly increases HDL

Decrases LDL

Red, flushed face, hyperglycemia, hyperuricemia

A

Niacin

(Vit B3)

Flushing reduced by aspirin

Hyperglycemia may cause acanthosis nigricans

23
Q

Prevent intestinal reabsorption of bile acids

(Liver uses cholesterol to make more bile)

Decreases LDL

Bad taste, GI discomfort, malabsorption of fat-soluble vitamins, cholesterol gallstones

A

Bile acid resins

Cholestyramine, colestipol, colesevelam

24
Q

Prevents cholesterol reabsorption

at small intestine brush border

Decreases LDL

Rare hepatotoxicity, diarrhea

A

Cholesterol absorption blockers

Ezetimibe

25
**Upregulates lipoprotein lipase (LPL)** (Increases triglyceride clearance) **Greatly reduces triglycerides** Myositis, hepatotoxicity, cholesterol gallstones
_Fibrates_ **Gemfibrozil, clofibrate, bezafibrate, fenofibrate**
26
**Inhibits Na+/K+ ATPase** **indirectly inhibits Na+/Ca2+ antiport** **increases Ca2+ in cells (positive inotropy)** **Stimulates vagus nerve to decrease HR** CHF, atrial fibrillation
_Cardiac glycosides_ **Digoxin** **CHF - increases contractility** **A fib - decreases conduction at AV, depresses SA**
27
Drug causes **Increased PR interval, decreased QT**, ST scooping, T-wave inversion, arrhythmia, AV block Can lead to hyperkalemia Exceted in urine **Renal failure, hypokalemia (allows binding), quinidine (displaces from tissue binding sites):** **Increase toxicity**
Digoxin
28
**Nausea, vomiting, diarrhea, blurry yellow vision** (Cholinergic effects) Treatment for OD?
Digoxin **Normalize K+, lidocaine, cardiac pacer, anti-dig Fab fragments, MG2+**
29
Local anesthetics **Slow or block conduction** **Decrease slope of phase 0** Increase threshold for firing in abnormal pacemaker cells Hyperkalemia increases toxicity
_Class I antiarrhythmics_ **Na+ channel blockers**
30
Increases: **AP duration, effective refractory period, QT interval** For both atrial and ventricular **arrhythmias** esp reentrant and ectopic SVT, VT **Thrombocytopenia, torsades de pointes**
_Class IA :_ **"PRO QUIN DI"** Quinidine, procainamide, disopyramide **Quin - cinchonism, headaches, tinnitus** **Pro - reversible SLE syndrome** **Diso - heart failure**
31
_Decreases:_ **AP duration** Preferentially affects ischemic/depolarized Purkinje and ventricular tissue **Acute ventricular arrhythmias (_post-MI_), digitalis induced arrhythmias** CNS stimulation/depression, cardiovascular depression
_Class IB: _"**I**'d **B**uy **L**iddy's funny (Pheny) M**ex**ican **Taco**s" **Lidocaine, Mexiletine, Tocainide**
32
**No effect on AP duration** **V-tach that progresses to V-fib, intractible SVT** Prolongs refractory period in AV node **Contraindicated with structural abnormalities, MI** **Proarrhythmic**
_Class IC:_ "**F**or **P**ushing Extasy" **Flecainide, propafenone**
33
Class 1 A, IB and IC (Na+ blockers) Mneumonic:
"**Police Department Questions** (Class 1A-AP increases)- **The Little Man** (Class 1B-AP decreases) - **For Pushing Extasy** (Class 1C-No change in AP)"
34
**Decreases cAMP, Ca2+ current in SA, AV nodes** Decreased nodal activity, esp AV node **(inc. PR)** Decreases phase 4 in abnormal pacemakers **V-tach, SVT** **Slows ventricular rate in A-fib and A-flutter** _Impotence_, bradycardia, AV block, CHF, CNS depression
_Class II:_ Beta-blockers Metoprolol, propranolol, esmolol, atenolol, timolol **Metoprolol- dyslipidemia (Tx: glucagon)** **Propranolol- vasospasm in Prinzmetal's angina** **Esmolol- very short acting**
35
Which class II antiarrhythmic can **exarcerbate** **vasospasm** in Prinzmetal's angina?
**Propranolol**
36
**Increases AP duration, QT interval** **Increases effective refractory period** Used when other antiarrhythmics fail
_Class III:_ K+ channel blockers **Amiodarone, ibutilide, dofetilide, sotalol** **(AIDS)**
37
Toxicity of: **Sotalol, Ibutilide**
Sotalol - **torsades de pointes**, excessive beta-block Ibutilide - torsades de pointes
38
Toxicity of: **Amiodarone** Which function tests? Why does it have class I, II, III and IV effects?
**_Pulmonary fibrosis, hepatotoxicity, hypo/hyperthyroidism_** Corneal, skin deposits, photodermatitis neurologic effects, constipation bradycardia, heart block, CHF _Check PFTs, LFTs, TFTs_ **40% iodine by weight** **Amiodarone alters the lipid membrane**
39
Decreases conduction velocity **Increases effective refractory period, PR interval** Prevents nodal arrhythmias (SVT) Constipation, flushing, edema, CHF, AV block, sinus node depression
_Class IV:_ Ca2+ channel blockers **Verapamil, diltiazem**
40
**Increases K+ outflow** **Hyperpolarizes cell, decreases Ca2+ in** (Na+/Ca2+ antiport) **_Abolishes SVT (first line)_** Very _short acting_ (15 seconds) Flushing, hypotension, chest pain What blocks all effects? (2)
**Adenosine** Effects blocked by _theophylline_ and _caffeine_
41
**For torsades de pointes, digoxin toxicity**
Mg2+
42